Cero Therapeutics Holdings (CERO) Payables (2021 - 2026)
Cero Therapeutics Holdings (CERO) reported Payables of $9.05 million for Q2 2026, up 45.6% from $6.21 million a year earlier and up 16.4% from the prior quarter.
Powered by 
Analysis
Cero Therapeutics Holdings (CERO) Payables (2021 - 2026) Analysis & Trends
At the end of FY2025, Cero Therapeutics Holdings posted Payables of $7.67 million, up 66.9% from FY2024.
- Payables has a four-year compound annual growth rate of 380.1% (FY2021 to FY2025).
- By year, Payables came in at $4.59 million in FY2024 (+102.2%), $2.27 million in FY2023 (-1.4%), $2.3 million in FY2022 and $14,433 in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Payables in data going back to Q4 2021.
- Year over year, Payables has now increased in each of the last four quarters, with growth averaging 33.1% over the last eight quarters.
- The high point for year-over-year Payables in five years was Q3 2023 (growth of 562.5%); the low point was Q1 2025 (a decline of 14.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $7.77 million (Q1 2026), $7.67 million (Q4 2025) and $7.08 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 18.17 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 5.96 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 7.03 Bn |
| 10 | Cero Therapeutics Holdings | 638,128.24 | -4.84 Mn | - | 9.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.05 Mn |
| Mar 31, 2026 | 7.77 Mn |
| Dec 31, 2025 | 7.67 Mn |
| Sep 30, 2025 | 7.08 Mn |
| Jun 30, 2025 | 6.21 Mn |
| Mar 31, 2025 | 6.38 Mn |
| Dec 31, 2024 | 4.59 Mn |
| Sep 30, 2024 | 6.77 Mn |
| Jun 30, 2024 | 6.60 Mn |
| Mar 31, 2024 | 7.46 Mn |
| Dec 31, 2023 | 2.27 Mn |
| Sep 30, 2023 | 4.71 Mn |
| Jun 30, 2023 | 4.32 Mn |
| Mar 31, 2023 | 2.67 Mn |
| Dec 31, 2022 | 2.30 Mn |
| Sep 30, 2022 | 710,355.00 |
| Jun 30, 2022 | 163,003.00 |
| Mar 31, 2022 | 121,342.00 |
| Dec 31, 2021 | 14,433.00 |
API Access
Cero Therapeutics Holdings Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=CERO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "CERO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=CERO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();